Does Stopping Aspirin Differ Fundamentally From Not Starting Aspirin in the Primary Prevention of Cardiovascular Disease Among Older Adults?-Reference-Cited by-同舟云学术

Does Stopping Aspirin Differ Fundamentally From Not Starting Aspirin in the Primary Prevention of Cardiovascular Disease Among Older Adults?

Published:2022-05 Issue:5 Volume:175 Page:757-758
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Murphy Ella¹,McEvoy John W.²^ORCID

Affiliation:

1. University Hospital Galway, Saolta University Health Care Group, and National University of Ireland Galway, Galway, Ireland

2. University Hospital Galway, Saolta University Health Care Group, National University of Ireland Galway, and National Institute for Prevention and Cardiovascular Health, National University of Ireland Galway, Galway, Ireland

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Reference10 articles.

1. The rise and fall of aspirin in the primary prevention of cardiovascular disease

2. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

3. Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly

4. Aspirin for cardiovascular disease prevention among adults in the United States: Trends, prevalence, and participant characteristics associated with use

5. Mind the Gap: Primary Prevention Aspirin and the Danger of Suboptimal Implementation of Contemporary Guidelines Into Clinical Practice

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short- and long-term impact of aspirin cessation in older adults: a target trial emulation;BMC Medicine;2024-07-29

2. Use of aspirin in cardiovascular disease prevention—the role of online information search;Chronic Illness;2024-04-07

3. An international perspective on low-dose aspirin for the primary prevention of myocardial infarction;International Journal of Cardiology;2023-02

4. Triggering of ST-elevation myocardial infarction by ultrafine particles in New York: Changes following Tier 3 vehicle introduction;Environmental Research;2023-01